The nucleotide sequence of RNA 3 of two subgroup I strains of cucumber mosaic virus (CMV), Fny-CMV and M-CMV, was determined and compared at both the nucleic acid and protein level with the previously determined, corresponding (partial) sequences of RNA 3 of five other subgroup I strains: C-CMV, D-CMV, I17F-CMV, O-CMV and Y-CMV. Fny-CMV RNA 3 is composed of 2216 nucleotides (nt) and M-CMV RNA 3 2214 nt. Both RNAs contain two open reading frames, the 3a gene and the coat protein gene. These RNAs showed very little nucleotide sequence divergence, either from each other or from the five other subgroup I strains. The nucleotide sequence variation observed was two to 13 differences in the 120 to 123 nt 5' non-translated regions, six to 17 differences in the 840 nt 3a genes, two to 15 differences in the 296 to 299 nt intergenic regions, three to 25 differences in the 657 nt coat protein genes and two to 10 differences in the 299 to 303 nt 3' non-translated regions. Protein sequence similarity was also high, with one to four differences in the 279 amino acids of the 3a proteins and two to 13 differences in the 218 amino acids of the coat proteins. Limited nucleotide sequence variation among nine strains of CMV was also shown using an RNA protection assay and a probe specific for Fny-CMV RNA 3. The limited variation shown by RNA 3 of strains of CMV with different passage histories, isolated in different countries over a 50 year period, suggests that the maintenance of the highly conserved nucleotide sequence may be important for other viral RNA functions or interactions.
Introduction
Cucumber mosaic virus (CMV) is a positive-sense, tripartite RNA plant virus, with a broad host range and world-wide distribution (Kaper & Waterworth, 1981) . RNAs 1 and 2 of CMV are associated with the replication of the viral genome (Nitta et at., 1988a) , whereas RNA 3 contains both the viral coat protein gene and the 3a gene, which encodes a protein thought to be involved in the cell-to-cell movement of CMV (Davies & Symons, 1988 ; and references therein). There are many strains of CMV which differ in host range and pathogenicity (Douine et al., 1979; Kaper & Waterworth, 1981) . Differences in various biological and physical properties between such strains have been mapped to specific RNAs by pseudorecombination. Thus, RNA 3 of the M strain of CMV (M-CMV), which encodes the viral coat protein, is associated with a loss of aphid transmissibility (Mossop & Francki, 1977) , an inability to infect some cultivars of Cucurbita pepo (squash; Shintaku & Palukaitis, 1990) , an altered t Present address: Correlation Genetics Corporation, 2050 Concourse Drive, San Jose, California 95131, U.S.A. 0000-9521 © 1990 SGM particle stability (Mossop et al., 1976; Mossop & Francki, 1977) and the induction of systemic chlorosis in tobacco (Rao & Francki, 1982) .
From a study of nucleic acid sequence homology, over 25 strains of CMV were divided into two subgroups (Gonda & Symons, 1978; Piazzolla et al., 1979; Owen & Palukaitis, 1988) . Those in subgroup I varied little in nucleotide sequence (Owen & Palukaitis, 1988) . These conclusions have been supported by a comparison of the partial nucleotide sequences of RNA 3 from four strains of subgroup I and two strains in subgroup II (Hayakawa et al., 1989; Quemada et al., 1989) . In this manuscript, we present the complete nucleotide sequences of RNA 3 from two subgroup I strains, Fny-CMV and M-CMV, and compare these nucleotide sequences and their encoded, putative amino acid sequences with those of other subgroup I strains with biological/physical properties similar to Fny-CMV.
Methods
Virus strains, propagation and purification. Most CMV strains were from sources previously indicated (Owen & Palukaitis, 1988) . M-CMV (Mossop et al., 1976) was obtained from R. Francki (University of Adelaide, South Australia) and Price's yellow strain (PY-CMV; Price, 1934) was obtained from H. Murakishi (Michigan State University, East Lansing, Mich., U.S.A.). All strains were propagated and purified as previously described (Palukaitis & Zaitlin, 1984) , except M-CMV which was propagated in either Nicotiana tabacum cv. Xanthi nc or N. clevelandii and purified as described by Mossop et al. (1976) . RNAs were extracted, concentrated and quantified as described previously (Palukaitis & Zaitlin, 1984) .
Construction and sequencing of cDNA clones. A cDNA clone of Fny-CMV RNA 3 was transferred from pUC 18 to pBSMI 3 -, as previously described, to make pBS-Fny3 (Owen & Palukaitis, 1988) which contained nucleotides (nt) 320 to 2212 of CMV RNA 3. An ordered set of deletions was made for each strand of the cDNA insert using the exonuclease III method of the Erase-a-Base system (Promega). Nucleotide sequences were determined using the Sequenase Kit (U.S. Biochemicals) and/or the T7 Sequencing Kit (Pharmacia) by the method of Sanger et aL (1980) , as modified by the above manufacturers for dsDNA templates. The sequence of approximately 1100 nt of the 3' half of Fny-CMV RNA 3 was also determined by subcloning restriction fragments from pBS-Fny 3 into pBSM13-, preparing ssDNA and sequencing the respective inserts.
A cDNA library of M-CMV RNA was prepared in pUCI8, as described for the cloning of Fny-CMV RNAs (Owen & Palukaitis, 1988) . cDNA clones specific to M-CMV RNA 3 were detected by Southern blot hybridization (Maniatis et al., 1982) using 32p-labelled cDNA specific to Fny-CMV RNA 3, prepared by the oligolabelling method of Feinberg & Volgelstein (1983) . Several overlapping cDNA clones of M-CMV RNA 3 were used for the partial nucleotide sequence determination of the 5' half of RNA 3. For the 3' half, restriction fragments from larger cDNA clones were subcloned into pUC18 for sequence determination. In addition, five oligonucleotides were used as primers to determine the nucleotide sequences of areas that could not be obtained from the above subclones. By the above approach we were able to determine the complete nucleotide sequence of RNA 3, with approximately 75 ~ of the sequence determined on both strands of the cDNA clones. Differences between the nucleotide sequences of the coat protein genes of Fny-CMV RNA 3 and M-CMV RNA 3 were confirmed by direct sequencing of the RNA using oligonucleotide primers (Zimmern & Kaesberg, 1978) .
The 5 / 650 nt of both Fny-CMV and M-CMV RNA 3 was cloned into pUC19, after preparing ds cDNA by the method of Ahlquist (1986) using total viral RNA as the template. First strand cDNA synthesis was primed with an oligonucleotide (5'CACGCTAGCTGTGG-TACCGG Y) complementary to RNA 3 and corresponding to nt 631 to 650 of RNA 3. This oligonucleotide contains an NheI site. Second strand cDNA synthesis was primed with an oligonucleotide (5"GGATCCTAATACGACTCACTATAGGTAATCTTAC 3'), the 10 T-terminal nt of which correspond exactly to the 5' end of RNA 3 and the six 5'-terminal nt of which contain a BamHI site.
The Y-terminal sequence of Fny-CMV RNA 3 was determined by dideoxynucleotide chain termination (Zimmern & Kaesberg, 1978) using oligonucleotide primers complementary to nt 285 to 299 and 153 to 172. Only the first two 5' nt (GU) could not be obtained by this procedure. These terminal sequences, and the Y-terminal sequences of Fny-CMV RNA 4, were determined as described previously for Fny-CMV RNA 2 (Rizzo .
In vitro transcription. The cDNA clone of the 5' 647 nt of Fny-CMV RNA 3 was transferred into the vector pBSM13 -and is referred to as pBS-Fny-3.5'. After linearization with EcoRI and making the plasmid blunt-ended using the Klenow fragment of DNA polymerase I (Owen & Palukaitis, 1988) , radiolabelled minus-sense RNA transcripts of the 5' 647 nt of Fny-CMV RNA 3 were produced from pBS-Fny-3-5' using T3 RNA polymerase.
RNA protection assays. The RNA protection assay was performed by the method of Winter et al. (1985) with the modifications previously described (Owen & Palukaitis, 1988) . For each incubation, 1 x 105 c.p.m, of 32p-labelled minus-sense RNA was used. The marker was a DNA ladder (BRL) end-labelled with [~,-32p ]ATP according to standard protocols (Maniatis et aL, 1982) .
Results and Discussion
Sequence analysis of RNAs 3 of Fny-CMV and M-CMV have been chosen for a comprehensive analysis of nucleotide sequence divergence of viruses isolated over long periods of time. Fny-CMV was isolated from muskmelon in the early 1980s (Banik et al., 1983) , whereas M-CMV (Mossop et al., 1976) was isolated from Price's No. 6 strain of CMV (Price, 1934) during the 1930s. Thus, these strains are separated temporally by almost 50 years.
The nucleotide sequences of RNA 3 of the Fny strain and the M strain of CMV are shown in Fig. 1 . Fny-CMV RNA 3 contains 2216nt whereas M-CMV RNA 3 contains 2214 nt. The putative amino acid sequence of the 30K proteins (3a gene product; Schwinghamer & Symons, 1975 and the 25K proteins (coat protein; Habili & Francki, 1974; Schwinghamer & Symons, 1975 are shown in Fig. 2 . It is apparent that there is a high degree of conservation of both nucleotide and amino acid sequences between the RNAs 3 and their putative gene products in these two strains, with only 26 nt differences and 10 amino acid differences. The various non-translated regions (NTR) all show somewhat similar levels of nucleotide sequence divergence: two out of 119 nt in the 5' NTR, two out of 297 nt in the intergenic region (IGR) and two out of 303 nt in the 3' NTR. The nucleotide sequences of the 3a genes are more conserved (six changes in 840 nt) than those of the coat protein genes (14 changes in 657 nt). The corresponding amino acid sequences also show this difference in conservation, with two changes in the 279 amino acids of the 30K proteins and eight changes in the 218 amino acids of the coat proteins.
This high degree of conservation is surprising given the differences in biological and physical properties of the RNA 3 of M-CMV and of Fny-CMV. These data indicate that (i) strains of the same virus isolated from different geographical locations approximately 50 years apart show very little difference in nucleotide sequence, (ii) in spite of the degeneracy of the genetic code, CMV strains in the same subgroup show a strong conservation of both nucleotide and amino acid sequences, suggesting other, as yet unidentified, roles for the RNA molecule, and (iii) considerable differences in the biological/physi- 
(b)
Fny -CMV C-CMV There is remarkably little sequence variation within the 3a genes of the subgroup I strains of CMV. The variation in nucleotide sequence between the 3a genes (six to 17 changes in 840 nt) is not significantly less than that between their encoded amino acid sequences (one to four changes in 279 amino acids). Moreover, two of the amino acid replacements observed are conservative substitutions (Fig. 2a) . Thus, it appears that very little amino acid sequence variation occurs in the 30K proteins of CMV strains. However, it is not known whether any of the above four strains shows variation in host range that could be attributed to the putative function of the 3a protein, i.e. promoting the cell-to-cell movement of the virus. Moreover, there is much more variation in both amino acid and nucleotide sequence in the 3a genes when the two subgroups are compared (Nitta et al., 1988b; Hayakawa et al., 1989). Once again, the high conservation of nucleotide sequence observed between all these strains suggests some functionassociated constraints on sequence drift.
The IGR of RNA 3 of five subgroup I strains is also remarkably conserved. O-CMV RNA 3 shows more variation than the other strains, with two-thirds of the sequence variation occurring in the 5" leader sequence of O-CMV RNA 4 (nt 1183 to 1256). M-CMV RNA 3 shows only two nt differences from Fny-CMV RNA 3 in the IGR. One, a U to G transversion at nt 1213, is also observed in the other CMV strains and is in the 5' leader of RNA 4, whereas the second, a deletion of a G at nt 1075, is unique to M-CMV RNA 3 (Fig. 1) .
The coat protein genes of seven subgroup I strains again show a strong conservation of nucleotide sequences, with between two and 25 changes in 657 nt. There is slightly less conservation observed in the putative amino acid sequences of the respective coat proteins, two to 13 changes in 218 amino acids (Fig. 2b) , than among the 30K proteins (Fig. 2a) . Surprisingly, the coat protein of the M strain did not show more variation in sequence similarity, given the physical and biological differences in the coat protein of M-CMV compared with most other strains. There are eight amino acid differences between the coat proteins of Fny-CMV and M-CMV (Fig. 2b) . Of these, six represent conservative substitutions and/or replacements found in other strains. Only the Pro to Leu (position 129) and the Tyr to Cys (position 168) exchanges are unique to M-CMV. Since the coat protein of the C strain, which has also lost its aphid transmissibility (D. Gonsalves, personal communication), has only two amino acid differences with respect to Fny-CMV (an Arg to His at position 13 and a Tyr to Phe at position 168), it is suggested that the Tyr at position 168 may be essential for the aphid transmission of CMV. On the other hand, there are no obvious correlations between the other three properties ascribed to the coat protein of M-CMV and specific sequence changes. It is clear, however, that since C-CMV does not induce a systemic chlorosis in tobacco, loss of aphid transmissibilityper se does not correlate with chlorogenecity. Finally, given that the number of non-conservative differences in amino acid sequence are less than the number of altered properties, the data indicate one or more of the following: (i) some alterations are pleiotropic; (ii) some conservative amino acid replacements may alter a particular property; and/or (iii) silent nucleotide changes, i.e. those that do not result in an amino acid substitution, may alter a particular property, which suggests an interaction occurs between specific viral nucleotide sequences and the host cellular environment.
The nucleotide sequences of the 3' N T R , containing 299 to 303 nt, are very similar in the seven strains, showing only two to 10 alterations. The additional U residues at nt 2001 and 2002 of Fny-CMV R N A 3, which were also detected by an R N A protection/heterogeneity assay, distinguish Fny-CMV R N A 3 from all other C M V strains tested (Owen & Palukaitis, 1988) .
The 3' 180nt can be folded into the secondary structure model previously described for the 3'.ends of Fny-CMV R N A s 1 and 2 (Rizzo & Palukaitis, , 1989 and based on secondary structure models proposed by Ahlquist et al. (1981) and Rietveld et al. (1983) . The variation seen between different strains in this region is limited to either single nucleotide changes in the loops or to substitutions in the stems that would not be expected to alter the secondary structure model. Most of the variation in nucleotide sequence between the strains is observed in the 3' N T R , upstream of the 180 nt involved in the secondary structure model. All strains in either subgroup I or subgroup II of CMV sequenced to date have the same 3'-terminal 10 nt.
Analysis of the heterogeneity in C M V RNA 3 by an RNA heterogeneity assay
The conclusion that strains isolated from different countries over a 50 year p e r i o d vary very little in nucleotide sequence was also reached previously following the use of an R N A protection assay to analyse and map nucleotide sequence variation in the 3' 1800 nt of R N A 3 from eight subgroup I CMV strains (Owen & Palukaitis, 1988) . Both to extend these results to the 5' 400 nt of R N A 3 and to determine the reliability of the R N A protection assay for predicting sequence differences between RNAs, R N A from 10 subgroup I strains and four subgroup II strains was annealed with a 32p. labelled R N A complementary to the 5' 647 nt of Fny-C M V R N A 3. Fig. 3 shows that digestion of annealed Fig. 3 , which contains more 32p-labelled antisense R N A than the other lanes. The minor bands were also observed when the probe was annealed to the R N A of eight other subgroup I CMV strains (Fig. 3) , as well as to a positive sense transcript prepared from the same c D N A clone as the negative sense probe (results not shown). Thus, these bands are probably due to cleavage within the perfectly matched duplexes.
RNase digestion of M-CMV R N A annealed to the probe yielded no intact probe, but bands of 570, 370, 185, 93 and 90 nt (Fig. 3, lane 6 ) appeared that correspond to cleavages within the 5' 647 nt of M-CMV R N A 3 at nucleotides 90, 94 and 461, where it differs from Fny-CMV R N A 3. In addition to these fragments another, of 180 nt, appeared that was not expected. The formation of this band may reflect heterogeneity in the population of M-CMV RNA 3, as was observed in Fny-CMV RNA 3 by Owen & Palukaitis (1988) . Nevertheless, the results of the RNA protection assay are in reasonably good agreement with the results predicted from nucleotide sequence analysis.
The same assay, applied to RNAs of a number of other CMV strains (Fig. 3 ), showed that: (i) RNA of all of the subgroup I strains formed large RNase-resistant fragments; (ii) RNA of the subgroup II strains yielded only small fragments less than 50 nt in length; (iii) RNA 3 of K-CMV yielded smaller and more numerous fragments than the RNA of the other subgroup I CMV strains, as previously was observed in the 3' 1800 nt sequences (Owen & Palukaitis, 1988) ; (iv) every other subgroup I CMV strain shows a similar, but distinct, pattern of nucleotide sequence variation relative to Fny-CMV RNA 3; (v) strains PY, Sny, D, T, Pf and G all showed a doublet of 185 and 180 nt, as was observed for M-CMV; (vi) strain PY, originally isolated in the 1930s, showed no more variation than strains isolated in the 1960s or 1980s; (vii) no other strain showed any completely protected probe, suggesting that all of the strains analysed contained some sequence variation around nucleotides 80 to 95 and probably additional variation 5' to this position, as was observed in the four subgroup I strains that have been sequenced. Thus, the RNA protection assay is a generally reliable indicator of nucleotide sequence heterogeneity and also shows that strains of CMV in subgroup I contain remarkably little variation in nucleotide sequence. By contrast, there is considerable divergence in nucleotide sequence between the two subgroups of CMV (Nitta et al., 1988b; Rizzo & Palukaitis, 1988; Hayakawa et al., 1989) . The nature of any constraints on further sequence divergence is unknown, although they appear to be expressed over long periods of time and in different environments.
